Ushbu ish iqtibos qilgan ishlar

321 ta ish

Ish: COVID-19 Vaccines - Current State and Perspectives

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer, Kyra H. Grantz, Qifang Bi +6
Maqola202010 iqtibos
ABI
Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan
Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5
MaqolaSARS-CoV-2 and COVID-19 ResearchPLoS ONE20229 iqtibos
ABI
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu +18
Maqola20208 iqtibos
ABI
Sarlavhasiz
Boshqa8 iqtibos
ABI
A new coronavirus associated with human respiratory disease in China
Fan Wu, Zhao Su, Bin Yu +16
Maqola20208 iqtibos
ABI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Maqola20208 iqtibos
ABI
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser +21
Maqola20207 iqtibos
ABI
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan
А. А. Абдуллаев, Abrorjon Abdurakhimov, Zebinisa Mirakbarova +6
MaqolaSARS-CoV-2 and COVID-19 ResearchPLoS ONE20226 iqtibos
ABI
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai +26
Maqola20216 iqtibos
ABI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Maqola20206 iqtibos
ABI
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett +5
Maqola20205 iqtibos
ABI
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study.
Kim Delbaere, Jacqueline Close, Henry Brodaty +2
Maqola20105 iqtibos
ABI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28
Maqola20215 iqtibos
ABI
Vaccine hesitancy: Definition, scope and determinants
Noni E. MacDonald
Maqola20154 iqtibos
ABI
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan, Jiwan Ge, Jinfang Yu +8
Maqola20204 iqtibos
ABI
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Sharh maqola20214 iqtibos
ABI
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong, Xi Mo, Yabin Hu +4
Maqola20204 iqtibos
ABI
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Maqola20214 iqtibos
ABI
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
Ruiyun Li, Sen Pei, Бин Чэн +4
Maqola20203 iqtibos
ABI
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici +47
Maqola20203 iqtibos
ABI
Genotype and phenotype of COVID-19: Their roles in pathogenesis
Leila Mousavizadeh, Sorayya Ghasemi
Sharh maqola20203 iqtibos
ABI
Circular RNA: A new star of noncoding RNAs
Shibin Qu, Xisheng Yang, Xiaolei Li +6
Sharh maqola20153 iqtibos
ABI
Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
Xin Zhao, Dedong Li, Wenjing Ruan +9
Boshqa20223 iqtibos
ABI
Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
Mahnaz Ghaebi, Abdolreza Osali, Hamed Valizadeh +2
Sharh maqola20203 iqtibos
ABI
Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra +4
Sharh maqola20203 iqtibos
ABI